Novartis

February 4, 2019
Categories

Cell & Gene Therapy: Increasing Demand for Viral Vectors Drives Biomanufacturing Innovation & CDMO Investment

Do you like it?
Read more
June 4, 2018
Categories

The Future of BioManufacturing: In Silico Modelling

Do you like it?
Read more
September 26, 2017
Categories

The Future of BioManufacturing: Cell Line Engineering

Do you like it?
Read more
August 31, 2017
The CAR-T Revolution: Gilead’s $12B Acquisition of Kite Pharma & FDA Approval of Novartis’ Kymriah Signal Tipping Point for Promising Cancer Immunotherapies
Categories

The CAR-T Revolution: Gilead’s $12B Acquisition of Kite Pharma & FDA Approval of Novartis’ Kymriah Signal Tipping Point for Promising Cancer Immunotherapies

Do you like it?
Read more
November 29, 2016
Categories

Promising Autologous CAR-T Cell Therapies Stumble: is this the End, or Just the Beginning?

Do you like it?
Read more
February 21, 2016
Evolution Infographic: The Rise & Diversification of Biologics
Categories

Evolution Infographic: The Rise & Diversification of Biologics

For our latest Data Visualisation project, the Evolution Global Team analysed historical new drug approval statistics and the current clinical trials pipeline to identify trends that […]
Do you like it?
Read more
September 10, 2015
Evolution Analysis - Google, Sanofi, Novartis and the Race to Improve Diabetes Health Outcomes
Categories

Evolution Analysis – Google, Sanofi, Novartis and the Race to Improve Diabetes Health Outcomes

On August 31, 2015 Google Life Sciences and French pharma giant Sanofi announced that the two companies will work together on new digital technology and tools […]
Do you like it?
Read more
Contact Us